Ultrasound-derived VAT is more strongly associated with hepatic steatosis and metabolic dysfunction than BMI or waist circumference among adults at risk for MASLD.

GLP-1RA therapy significantly reduces the risk for new-onset heart failure in patients with type 2 diabetes or obesity, regardless of weight loss.

Medical school applications and enrollments grew in 2025, with the number of enrolled students reaching an all-time high.

A new tool provided a validated tumor recurrence and survival risk score for patients with lymph node-negative PanNETs.

Needle-knife techniques and EUS-RV may be optimal strategies for difficult biliary cannulation in endoscopic retrograde cholangiopancreatography.

Long-term surveillance of branch-duct IPMN shows a 5.5% 10-year risk for pancreatic cancer, with cyst wall thickening emerging as a key independent predictor.

The percentage of adolescents using alcohol, cannabis, nicotine, nicotine patches and vaping has remained low since decreasing in 2020.

The American Academy of Pediatrics filed a lawsuit against the US Department of Health and Human Services for its recent funding cuts.

Aetna agreed in a settlement to provide fertility treatment coverage for both same-sex and heterosexual couples nationwide.

High-fat cheese and cream intake was inversely associated with a lower risk for all-cause dementia, vascular dementia, and Alzheimer disease.

Gut microbiota profiles obtained at admission can predict postdischarge diabetes after acute pancreatitis with high accuracy, independent of disease severity. Microbiome characteristics at acute ...

The FDA has approved Wegovy (semaglutide) tablets, the first oral GLP-1 receptor agonist for the treatment of obesity.